Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 1998, p. 709-711, Vol. 42, No. 3
Public Health Research Institute, New York,
New York 10016,1 and
Redox
Pharmaceutical Corporation, Greenvale, New York
115482
Received 19 September 1997/Returned for modification 12 December
1997/Accepted 29 December 1997
Isoniazid (INH) activation in vitro is associated with reduction of
the mycobacterial ferric KatG catalase-peroxidase by hydrazine and
reaction with O2 to form an oxyferrous enzyme complex.
Since this complex could also form directly via reaction of ferric KatG with superoxide, intracellular activation might be responsive to
superoxide concentration. When Mycobacterium smegmatis
carrying the M. bovis katG gene was treated with nontoxic
levels of plumbagin, a generator of superoxide, the bacteriostatic
activity of INH increased unless a plasmid-borne superoxide dismutase
gene was also present. Thus, endogenous superoxide probably contributes to intracellular activation of INH.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Role of Superoxide in Catalase-Peroxidase-Mediated
Isoniazid Action against Mycobacteria
*
Corresponding author. Mailing address: Public Health
Research Institute, 455 First Ave., New York, NY 10016. Phone: (212) 576-8428. Fax: (212) 578-0804. E-mail:
burger{at}phri.nyu.edu.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |